Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Evaluation of Fetal and Maternal Vancomycin-Induced Kidney Injury during Pregnancy in a Rat Model.

Joshi MD, Pais GM, Chang J, Hlukhenka K, Avedissian SN, Gulati A, Prozialeck WC, Lamar PC, Zhang Z, Scheetz MH, Griffin B.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00761-19. doi: 10.1128/AAC.00761-19. Print 2019 Oct.

PMID:
31332061
2.

Fabrication of Nanostructured Lipid Carriers (NLC)-Based Gels from Microemulsion Template for Delivery Through Skin.

Joshi MD, Prabhu RH, Patravale VB.

Methods Mol Biol. 2019;2000:279-292. doi: 10.1007/978-1-4939-9516-5_19.

PMID:
31148022
3.

Twenty-four hour pharmacokinetic relationships for intravenous vancomycin and novel urinary biomarkers of acute kidney injury in a rat model.

Avedissian SN, Pais GM, O'Donnell JN, Lodise TP, Liu J, Prozialeck WC, Joshi MD, Lamar PC, Becher L, Gulati A, Hope W, Scheetz MH.

J Antimicrob Chemother. 2019 Aug 1;74(8):2326-2334. doi: 10.1093/jac/dkz167.

PMID:
31065686
4.

A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.

Avedissian SN, Pais G, Joshi MD, Rhodes NJ, Scheetz MH.

mSphere. 2019 Jan 30;4(1). pii: e00595-18. doi: 10.1128/mSphere.00595-18.

5.

Towards long-acting adrenaline for cardiopulmonary resuscitation: Production and characterization of a liposomal formulation.

Schlich M, Sinico C, Valenti D, Gulati A, Joshi MD, Meli V, Murgia S, Xanthos T.

Int J Pharm. 2019 Feb 25;557:105-111. doi: 10.1016/j.ijpharm.2018.12.044. Epub 2018 Dec 23.

PMID:
30586629
6.

Drug delivery during pregnancy: how can nanomedicine be used?

Joshi MD.

Ther Deliv. 2017 Dec;8(12):1023-1025. doi: 10.4155/tde-2017-0084. No abstract available.

PMID:
29125062
7.

24-Hour Pharmacokinetic Relationships for Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury.

O'Donnell JN, Rhodes NJ, Lodise TP, Prozialeck WC, Miglis CM, Joshi MD, Venkatesan N, Pais G, Cluff C, Lamar PC, Briyal S, Day JZ, Gulati A, Scheetz MH.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e00416-17. doi: 10.1128/AAC.00416-17. Print 2017 Nov.

8.

Dose, duration, and animal sex predict vancomycin-associated acute kidney injury in preclinical studies.

O'Donnell JN, Rhodes NJ, Miglis CM, Catovic L, Liu J, Cluff C, Pais G, Avedissian S, Joshi MD, Griffin B, Prozialeck W, Gulati A, Lodise TP, Scheetz MH.

Int J Antimicrob Agents. 2018 Feb;51(2):239-243. doi: 10.1016/j.ijantimicag.2017.08.012. Epub 2017 Aug 10. Review.

9.

High-Performance Liquid Chromatography Method for Rich Pharmacokinetic Sampling Schemes in Translational Rat Toxicity Models With Vancomycin.

Joshi MD, O'Donnell JN, Venkatesan N, Chang J, Nguyen H, Rhodes NJ, Pais G, Chapman RL, Griffin B, Scheetz MH.

Clin Transl Sci. 2017 Nov;10(6):496-502. doi: 10.1111/cts.12484. Epub 2017 Jul 4.

10.

Glucose-lowering therapies, adequacy of metabolic control, and their relationship with comorbid depression in outpatients with type 2 diabetes in a tertiary hospital in Kenya.

Otieno CF, Kanu JE, Karari EM, Okech-Helu V, Joshi MD, Mutai K.

Diabetes Metab Syndr Obes. 2017 Apr 28;10:141-149. doi: 10.2147/DMSO.S124473. eCollection 2017.

11.

Quality of sleep and risk for obstructive sleep apnoea in ambulant individuals with type 2 diabetes mellitus at a tertiary referral hospital in Kenya: a cross-sectional, comparative study.

Sokwalla SM, Joshi MD, Amayo EO, Acharya K, Mecha JO, Mutai KK.

BMC Endocr Disord. 2017 Feb 6;17(1):7. doi: 10.1186/s12902-017-0158-6.

12.

Acute Kidney Injury Following Cardiac Surgery in Neonates and Young Infants: Experience of a Single Center Using Novel Perioperative Strategies.

Kumar TK, Allen Ccp J, Spentzas Md T, Berrios Ccp L, Shah Md S, Joshi Md VM, Ballweg Md JA, Knott-Craig Md CJ.

World J Pediatr Congenit Heart Surg. 2016 Jul;7(4):460-6. doi: 10.1177/2150135116648305.

PMID:
27358301
14.

Evaluation of liposomal nanocarriers loaded with ETB receptor agonist, IRL-1620, using cell-based assays.

Joshi MD, Oesterling BM, Wu C, Gwizdz N, Pais G, Briyal S, Gulati A.

Neuroscience. 2016 Jan 15;312:141-52. doi: 10.1016/j.neuroscience.2015.11.016. Epub 2015 Nov 18.

PMID:
26592721
15.

Polymeric nanoparticles for targeted treatment in oncology: current insights.

Prabhu RH, Patravale VB, Joshi MD.

Int J Nanomedicine. 2015 Feb 2;10:1001-18. doi: 10.2147/IJN.S56932. eCollection 2015. Review.

16.

Prevalence of hypertension and associated cardiovascular risk factors in an urban slum in Nairobi, Kenya: a population-based survey.

Joshi MD, Ayah R, Njau EK, Wanjiru R, Kayima JK, Njeru EK, Mutai KK.

BMC Public Health. 2014 Nov 18;14:1177. doi: 10.1186/1471-2458-14-1177.

17.

Parasite impairment by targeting Plasmodium-infected RBCs using glyceryl-dilaurate nanostructured lipid carriers.

Jain SA, Basu H, Prabhu PS, Soni U, Joshi MD, Mathur D, Patravale VB, Pathak S, Sharma S.

Biomaterials. 2014 Aug;35(24):6636-45. doi: 10.1016/j.biomaterials.2014.04.058. Epub 2014 May 10.

PMID:
24818881
18.

Nanocarrier-based approaches for treatment and detection of Alzheimer's disease.

Oesterling BM, Gulati A, Joshi MD.

J Nanosci Nanotechnol. 2014 Jan;14(1):137-56. Review.

PMID:
24730256
19.

Peptide Vaccine: Progress and Challenges.

Li W, Joshi MD, Singhania S, Ramsey KH, Murthy AK.

Vaccines (Basel). 2014 Jul 2;2(3):515-36. doi: 10.3390/vaccines2030515. Review.

20.

Determination of polychlorinated biphenyls in ocean water and bovine milk using crosslinked polymeric ionic liquid sorbent coatings by solid-phase microextraction.

Joshi MD, Ho TD, Cole WT, Anderson JL.

Talanta. 2014 Jan;118:172-9. doi: 10.1016/j.talanta.2013.10.014. Epub 2013 Oct 14.

PMID:
24274285
21.

Using glucaminium-based ionic liquids for improving the separation of 2-aminopyrimidine-5-ylboronic acid and its pinacol ester by high performance liquid chromatography.

Joshi MD, Li T, Zhong Q, Anderson JL.

J Chromatogr A. 2013 Sep 20;1308:161-5. doi: 10.1016/j.chroma.2013.07.108. Epub 2013 Aug 6.

PMID:
23958694
22.

A population-based survey of prevalence of diabetes and correlates in an urban slum community in Nairobi, Kenya.

Ayah R, Joshi MD, Wanjiru R, Njau EK, Otieno CF, Njeru EK, Mutai KK.

BMC Public Health. 2013 Apr 20;13:371. doi: 10.1186/1471-2458-13-371.

23.

Observer variability of an angiographic grading scale used for the assessment of intracranial aneurysms treated with flow-diverting stents.

Joshi MD, O'Kelly CJ, Krings T, Fiorella D, Marotta TR.

AJNR Am J Neuroradiol. 2013 Aug;34(8):1589-92. doi: 10.3174/ajnr.A3431. Epub 2013 Feb 28.

24.

Ionic liquids as solvents for in situ dispersive liquid-liquid microextraction of DNA.

Li T, Joshi MD, Ronning DR, Anderson JL.

J Chromatogr A. 2013 Jan 11;1272:8-14. doi: 10.1016/j.chroma.2012.11.055. Epub 2012 Nov 28.

PMID:
23261290
25.

Evaluating the complexation behavior and regeneration of boron selective glucaminium-based ionic liquids when used as extraction solvents.

Joshi MD, Steyer DJ, Anderson JL.

Anal Chim Acta. 2012 Aug 31;740:66-73. doi: 10.1016/j.aca.2012.06.035. Epub 2012 Jun 28.

PMID:
22840652
26.

Targeting tumor antigens to dendritic cells using particulate carriers.

Joshi MD, Unger WJ, Storm G, van Kooyk Y, Mastrobattista E.

J Control Release. 2012 Jul 10;161(1):25-37. doi: 10.1016/j.jconrel.2012.05.010. Epub 2012 May 10. Review.

PMID:
22580109
27.

Selective extraction of genotoxic impurities and structurally alerting compounds using polymeric ionic liquid sorbent coatings in solid-phase microextraction: Alkyl halides and aromatics.

Ho TD, Joshi MD, Silver MA, Anderson JL.

J Chromatogr A. 2012 Jun 1;1240:29-44. doi: 10.1016/j.chroma.2012.03.080. Epub 2012 Apr 3.

PMID:
22537606
28.

MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells.

Rajabi H, Ahmad R, Jin C, Joshi MD, Guha M, Alam M, Kharbanda S, Kufe D.

Prostate. 2012 Nov;72(15):1659-68. doi: 10.1002/pros.22519. Epub 2012 Apr 2.

29.

MUC1-C oncoprotein induces TCF7L2 transcription factor activation and promotes cyclin D1 expression in human breast cancer cells.

Rajabi H, Ahmad R, Jin C, Kosugi M, Alam M, Joshi MD, Kufe D.

J Biol Chem. 2012 Mar 23;287(13):10703-13. doi: 10.1074/jbc.M111.323311. Epub 2012 Feb 8.

30.

Dissecting electrostatic interactions in Bacillus circulans xylanase through NMR-monitored pH titrations.

McIntosh LP, Naito D, Baturin SJ, Okon M, Joshi MD, Nielsen JE.

J Biomol NMR. 2011 Sep;51(1-2):5-19. doi: 10.1007/s10858-011-9537-x. Epub 2011 Sep 27.

PMID:
21947911
31.

Synthesis of glucaminium-based ionic liquids and their application in the removal of boron from water.

Joshi MD, Chalumot G, Kim YW, Anderson JL.

Chem Commun (Camb). 2012 Feb 1;48(10):1410-2. doi: 10.1039/c1cc14327a. Epub 2011 Sep 12.

PMID:
21909577
32.

DC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.

Joshi MD, Unger WW, van Beelen AJ, Bruijns SC, Litjens M, van Bloois L, Kalay H, van Kooyk Y, Storm G.

Int J Pharm. 2011 Sep 20;416(2):426-32. doi: 10.1016/j.ijpharm.2011.02.055. Epub 2011 Mar 1.

PMID:
21371544
33.

MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop.

Ahmad R, Rajabi H, Kosugi M, Joshi MD, Alam M, Vasir B, Kawano T, Kharbanda S, Kufe D.

Sci Signal. 2011 Feb 15;4(160):ra9. doi: 10.1126/scisignal.2001426.

34.

Androgen receptor regulates expression of the MUC1-C oncoprotein in human prostate cancer cells.

Rajabi H, Joshi MD, Jin C, Ahmad R, Kufe D.

Prostate. 2011 Sep;71(12):1299-308. doi: 10.1002/pros.21344. Epub 2011 Feb 9.

35.

MUCIN 1 ONCOPROTEIN EXPRESSION IS SUPPRESSED BY THE miR-125b ONCOMIR.

Rajabi H, Jin C, Ahmad R, McClary C, Joshi MD, Kufe D.

Genes Cancer. 2010 Jan 1;1(1):62-68.

36.

Biocompatible microemulsions for fabrication of glyceryl monostearate solid lipid nanoparticles (SLN) of tretinoin.

Shah KA, Joshi MD, Patravale VB.

J Biomed Nanotechnol. 2009 Aug;5(4):396-400.

PMID:
20055085
37.

Familial clustering of cancer in two tertiary care hospitals in Nairobi, Kenya.

Kiarie GW, Abinya NO, Joshi MD, Lule GN, Mutuma GZ.

East Afr Med J. 2010 Jan;87(1):9-13.

PMID:
23057297
38.

Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.

Khodarev N, Ahmad R, Rajabi H, Pitroda S, Kufe T, McClary C, Joshi MD, MacDermed D, Weichselbaum R, Kufe D.

Oncogene. 2010 Feb 11;29(6):920-9. doi: 10.1038/onc.2009.391. Epub 2009 Nov 16.

39.

MUC1 oncoprotein is a druggable target in human prostate cancer cells.

Joshi MD, Ahmad R, Yin L, Raina D, Rajabi H, Bubley G, Kharbanda S, Kufe D.

Mol Cancer Ther. 2009 Nov;8(11):3056-65. doi: 10.1158/1535-7163.MCT-09-0646. Epub 2009 Nov 3.

41.

MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor.

Ahmad R, Raina D, Joshi MD, Kawano T, Ren J, Kharbanda S, Kufe D.

Cancer Res. 2009 Sep 1;69(17):7013-21. doi: 10.1158/0008-5472.CAN-09-0523. Epub 2009 Aug 25.

42.

Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.

Raina D, Ahmad R, Joshi MD, Yin L, Wu Z, Kawano T, Vasir B, Avigan D, Kharbanda S, Kufe D.

Cancer Res. 2009 Jun 15;69(12):5133-41. doi: 10.1158/0008-5472.CAN-09-0854. Epub 2009 Jun 2.

43.

Fertility rate of epileptic women at Kenyatta National Hospital.

Kariuki JG, Joshi MD, Adam AM, Kwasa TO, Machoki M.

East Afr Med J. 2008 Jul;85(7):341-6.

PMID:
19133423
44.

Synthesis of alpha-amyrin derivatives and their in vivo antihyperglycemic activity.

Narender T, Khaliq T, Singh AB, Joshi MD, Mishra P, Chaturvedi JP, Srivastava AK, Maurya R, Agarwal SC.

Eur J Med Chem. 2009 Mar;44(3):1215-22. doi: 10.1016/j.ejmech.2008.09.011. Epub 2008 Sep 19.

PMID:
18947904
45.

Lipid nanoparticles for parenteral delivery of actives.

Joshi MD, Müller RH.

Eur J Pharm Biopharm. 2009 Feb;71(2):161-72. doi: 10.1016/j.ejpb.2008.09.003. Epub 2008 Sep 13. Review.

PMID:
18824097
46.

High-sensitivity C-reactive protein in type 2 diabetic patients with and without the metabolic syndrome.

Joshi MD, Wala J, Acharya KS, Amayo A.

East Afr Med J. 2008 Apr;85(4):178-86.

PMID:
18700351
47.

Investigation of monovalent and bivalent enantioselective molecular recognition by electrospray ionization-mass spectrometry and tandem mass spectrometry.

Schug KA, Joshi MD, Frycák P, Maier NM, Lindner W.

J Am Soc Mass Spectrom. 2008 Nov;19(11):1629-42. doi: 10.1016/j.jasms.2008.07.010. Epub 2008 Jul 17.

48.

Prevalence of dyslipidemia and dysglycaemia in HIV infected patients.

Manuthu EM, Joshi MD, Lule GN, Karari E.

East Afr Med J. 2008 Jan;85(1):10-7.

PMID:
18543521
49.
50.

Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.

Shah KA, Date AA, Joshi MD, Patravale VB.

Int J Pharm. 2007 Dec 10;345(1-2):163-71. Epub 2007 Jun 2.

PMID:
17644288

Supplemental Content

Loading ...
Support Center